These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24424199)

  • 1. The diagnosis and classification of autoimmune coagulopathy: an updated review.
    Chang HH; Chiang BL
    Autoimmun Rev; 2014; 13(4-5):587-90. PubMed ID: 24424199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired inhibitors.
    Cohen AJ; Kessler CM
    Baillieres Clin Haematol; 1996 Jun; 9(2):331-54. PubMed ID: 8800509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to coagulation factors: from pathophysiology to diagnosis and therapy.
    Cugno M; Gualtierotti R; Tedeschi A; Meroni PL
    Autoimmun Rev; 2014 Jan; 13(1):40-8. PubMed ID: 23954454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Coagulopathy with autoantibodies to blood-clotting factors: overview and laboratory diagnosis].
    Arai M
    Rinsho Byori; 2004 Feb; 52(2):178-81. PubMed ID: 15027324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors to clotting factors.
    Sallah S
    Ann Hematol; 1997; 75(1-2):1-7. PubMed ID: 9322677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired coagulation inhibitor-associated bleeding disorders: an update.
    Franchini M; Veneri D
    Hematology; 2005 Dec; 10(6):443-9. PubMed ID: 16321808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory, clinical and therapeutic aspects of acquired hemophilia A.
    Franchini M; Targher G; Montagnana M; Lippi G
    Clin Chim Acta; 2008 Sep; 395(1-2):14-8. PubMed ID: 18505682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired inhibitors of coagulation factors: part II.
    Franchini M; Lippi G; Favaloro EJ
    Semin Thromb Hemost; 2012 Jul; 38(5):447-53. PubMed ID: 22740184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired inhibitors of coagulation factors: part I-acquired hemophilia A.
    Coppola A; Favaloro EJ; Tufano A; Di Minno MN; Cerbone AM; Franchini M
    Semin Thromb Hemost; 2012 Jul; 38(5):433-46. PubMed ID: 22740182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of the presentation of coagulation factor VIII inhibitors in rheumatic diseases: A potential cause of life-threatening hemorrhage.
    O'Connor CR
    Semin Arthritis Rheum; 2015 Jun; 44(6):695-709. PubMed ID: 25595725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of rare acquired bleeding disorders.
    Menegatti M; Biguzzi E; Peyvandi F
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):80-87. PubMed ID: 31808848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New protocol for immune tolerance induction in acquired hemophilia.
    Nemes L; Pitlik E
    Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune coagulation disorders.
    Scott-Timperley LJ; Haire WD
    Rheum Dis Clin North Am; 1997 May; 23(2):411-23. PubMed ID: 9156400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acquired coagulant factor inhibitors].
    Nogami K
    Rinsho Ketsueki; 2015 Feb; 56(2):160-8. PubMed ID: 25765796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in managing rare acquired bleeding disorders.
    Franchini M; Marano G; Cruciani M; Mengoli C; Pati I; Masiello F; Veropalumbo E; Pupella S; Vaglio S; Liumbruno GM
    Expert Rev Hematol; 2020 Jun; 13(6):599-606. PubMed ID: 32286895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired circulating anticoagulants.
    Kunkel LA
    Hematol Oncol Clin North Am; 1992 Dec; 6(6):1341-57. PubMed ID: 1452516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The antiphospholipid antibody syndrome: its pathogenesis and clinico-morphological manifestations].
    Zerbino DD; Lukasevich LL; Bilynskaia OA
    Arkh Patol; 1990; 52(4):65-9. PubMed ID: 2117434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies.
    Holme PA; Brosstad F; Tjønnfjord GE
    Haemophilia; 2005 Sep; 11(5):510-5. PubMed ID: 16128896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immune-mediated acquired coagulation factor deficiencies: state-of-the-art in diagnosis and management].
    Ichinose A
    Rinsho Ketsueki; 2019; 60(6):667-679. PubMed ID: 31281160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.
    Reipert BM; van Helden PM; Schwarz HP; Hausl C
    Br J Haematol; 2007 Jan; 136(1):12-25. PubMed ID: 17222196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.